Capstone Investment Advisors, LLC Biogen Inc. Call Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $170,163 - $213,120	900 Added 13.85%	7,400 $1.43 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $495,352 - $615,472	2,600 Added 66.67%	6,500 $1.51 Million
Q1 2024 May 01, 2024	SELL	$212.02 - $267.71 $360,434 - $455,106	-1,700 Reduced 30.36%	3,900 $840,000
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $578,734 - $696,644	2,600 Added 86.67%	5,600 $1.45 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $177,310 - $200,123	700 Added 30.43%	3,000 $771,000
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $55,050 - $63,612	200 Added 9.52%	2,300 $655,000
Q1 2023 May 09, 2023	SELL	$256.56 - $292.34 $1.03 Million - $1.17 Million	-4,000 Reduced 65.57%	2,100 $583,000
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $25,244 - $30,672	100 Added 1.67%	6,100 $1.69 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $38,938 - $53,691	200 Added 3.45%	6,000 $1.6 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $900,192 - $1.07 Million	-4,800 Reduced 45.28%	5,800 $1.18 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $1.28 Million - $1.61 Million	-6,600 Reduced 38.37%	10,600 $2.23 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $447,840 - $575,540	-2,000 Reduced 10.42%	17,200 $4.13 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $2.66 Million - $3.47 Million	9,400 Added 95.92%	19,200 $5.43 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $828,800 - $1.33 Million	3,200 Added 48.48%	9,800 $3.39 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $97,180 - $113,852	400 Added 6.45%	6,600 $1.85 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $2.41 Million - $3.63 Million	-10,200 Reduced 62.2%	6,200 $1.52 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $556,017 - $641,991	2,100 Added 14.69%	16,400 $4.65 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $2.25 Million - $2.98 Million	8,700 Added 155.36%	14,300 $3.83 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $7.72 Million - $9.79 Million	-28,700 Reduced 83.67%	5,600 $1.77 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $1.76 Million - $2.43 Million	8,000 Added 30.42%	34,300 $10.2 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $1.28 Million - $1.44 Million	-5,900 Reduced 18.32%	26,300 $6.12 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $5.37 Million - $5.92 Million	24,500 Added 318.18%	32,200 $7.53 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $476,762 - $745,712	2,200 Added 40.0%	7,700 $1.82 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $417,750 - $529,125	1,500 Added 37.5%	5,500 $1.66 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $939,232 - $1.23 Million	3,200 Added 400.0%	4,000 $1.41 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $206,016 - $245,528	800 New	800 $232,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account